{"id":26405,"date":"2025-04-22T17:05:33","date_gmt":"2025-04-22T17:05:33","guid":{"rendered":"https:\/\/medexperts.pro\/?p=26405"},"modified":"2025-04-22T17:24:26","modified_gmt":"2025-04-22T17:24:26","slug":"at-meta-trial-instagram-co-founder-says-startup-was-denied-resources","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=26405","title":{"rendered":"At Meta Trial, Instagram Co-Founder Says Startup Was Denied Resources"},"content":{"rendered":"<div><\/div>\n<p id=\"article-summary\" class=\"css-79rysd e1wiw3jv0\">Kevin Systrom said during testimony in a landmark antitrust trial that he believed Meta viewed Instagram as a threat.<\/p>\n<section class=\"meteredContent css-1r7ky0e\">\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-0\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">Kevin Systrom, the co-founder of Instagram, testified on Tuesday in a <a class=\"css-yywogo\" href=\"https:\/\/www.nytimes.com\/2025\/04\/13\/technology\/meta-ftc-trial-whatsapp-instagram.html\" title>landmark federal antitrust trial<\/a> that he left Meta in 2018 because his company was denied resources.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">The government has argued that Meta purchased Instagram in 2012 as part of a \u201cbuy-or-bury strategy\u201d to illegally cement its social media monopoly by killing off its rivals. Last week, current and former Meta executives testified that the social media giant, formerly known as Facebook, used its deep pockets to invest in Instagram after its purchase.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">In testimony at the U.S. District Court of the District of Columbia, Mr. Systrom painted a different picture, saying he left Meta because Mark Zuckerberg, the chief executive, wasn\u2019t investing enough. At that time, Instagram had grown to 1 billion users, about 40 percent of Facebook\u2019s size, yet the photo-sharing app had only 1,000 employees compared to 35,000 employees at Facebook, he said.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">\u201cWe were by far the fastest growing team. We produced the most revenue and relative to what we should have been at the time, I felt like we should have been much larger,\u201d said Mr. Systrom, who is expected to testify for six hours.<\/p>\n<\/div>\n<\/div>\n<div data-testid=\"Dropzone-1\"><\/div>\n<div class=\"css-s99gbd StoryBodyCompanionColumn\" data-testid=\"companionColumn-1\">\n<div class=\"css-53u6y8\">\n<p class=\"css-at9mc1 evys1bk0\">Mr. Systrom said he found the decisions baffling. When asked by an F.T.C. lawyer why Mr. Zuckerberg might have decided to give Instagram fewer resources, Mr. Systrom said it was a consistent pattern during his tenure at Meta.<\/p>\n<p class=\"css-at9mc1 evys1bk0\">\u201cMark was not investing in Instagram because he believed we were a threat to their growth,\u201d he said, referring to Mr. Zuckerberg\u2019s prioritization of Facebook.<\/p>\n<div class=\"css-kbghgg\">\n<div class=\"css-121kum4\">\n<div class=\"css-171quhb\"><\/div>\n<div class=\"css-asuuk5\">\n<div class=\"css-7axq9l\" data-testid=\"optimistic-truncator-noscript\">\n<div data-testid=\"optimistic-truncator-noscript-message\" class=\"css-6yo1no\">\n<p class=\"css-3kpklk\">We are having trouble retrieving the article content.<\/p>\n<p class=\"css-3kpklk\">Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n<div class=\"css-1dv1kvn\" id=\"optimistic-truncator-a11y\">\n<hr \/>\n<p>Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0<a href=\"https:\/\/myaccount.nytimes.com\/auth\/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F04%2F22%2Ftechnology%2Fmeta-trial-instagram-kevin-systrom.html&amp;asset=opttrunc\">log into<\/a>\u00a0your Times account, or\u00a0<a href=\"https:\/\/www.nytimes.com\/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F04%2F22%2Ftechnology%2Fmeta-trial-instagram-kevin-systrom.html\">subscribe<\/a>\u00a0for all of The Times.<\/p>\n<hr \/>\n<\/div>\n<div class=\"css-1g71tqy\">\n<div data-testid=\"optimistic-truncator-message\" class=\"css-6yo1no\">\n<p class=\"css-3kpklk\">Thank you for your patience while we verify access.<\/p>\n<p class=\"css-3kpklk\">Already a subscriber?\u00a0<a data-testid=\"log-in-link\" class=\"css-z5ryv4\" href=\"https:\/\/myaccount.nytimes.com\/auth\/login?response_type=cookie&amp;client_id=vi&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F04%2F22%2Ftechnology%2Fmeta-trial-instagram-kevin-systrom.html&amp;asset=opttrunc\">Log in<\/a>.<\/p>\n<p class=\"css-3kpklk\">Want all of The Times?\u00a0<a data-testid=\"subscribe-link\" class=\"css-z5ryv4\" href=\"https:\/\/www.nytimes.com\/subscription?campaignId=89WYR&amp;redirect_uri=https%3A%2F%2Fwww.nytimes.com%2F2025%2F04%2F22%2Ftechnology%2Fmeta-trial-instagram-kevin-systrom.html\">Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Kevin Systrom said during testimony in a landmark antitrust trial that he believed Meta viewed Instagram as a threat.Kevin Systrom, the co-founder of Instagram, testified on Tuesday in a landmark federal antitrust trial that he left Meta in 2018 because his company was denied resources.The government has argued that Meta purchased Instagram in 2012 as part of a \u201cbuy-or-bury strategy\u201d to illegally cement its social media monopoly by killing off its rivals. Last week, current and former Meta executives testified that the social media giant, formerly known as Facebook, used its deep pockets to invest in Instagram after its purchase.In testimony at the U.S. District Court of the District of Columbia, Mr. Systrom painted a different picture, saying he left Meta because Mark Zuckerberg, the chief executive, wasn\u2019t investing enough. At that time, Instagram had grown to 1 billion users, about 40 percent of Facebook\u2019s size, yet the photo-sharing app had only 1,000 employees compared to 35,000 employees at Facebook, he said.\u201cWe were by far the fastest growing team. We produced the most revenue and relative to what we should have been at the time, I felt like we should have been much larger,\u201d said Mr. Systrom, who is expected to testify for six hours.Mr. Systrom said he found the decisions baffling. When asked by an F.T.C. lawyer why Mr. Zuckerberg might have decided to give Instagram fewer resources, Mr. Systrom said it was a consistent pattern during his tenure at Meta.\u201cMark was not investing in Instagram because he believed we were a threat to their growth,\u201d he said, referring to Mr. Zuckerberg\u2019s prioritization of Facebook.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":26407,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-26405","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/26405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26405"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/26405\/revisions"}],"predecessor-version":[{"id":26408,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/26405\/revisions\/26408"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/26407"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}